US Employers Say Government Drug Pricing Reforms Needed To Supplement Market-Based Efforts

Annual Business Group on Health survey on employer-sponsored insurance covers pricing reform, rebate model alternatives, paying for high-cost drugs and copay coupons.

Employers are bracing For high-cost treatments In 2023/2024. • Source: Alamy

Government reforms aimed at lowering drug prices are needed because market-based reforms haven’t been able to bring about enough change, according to a recent survey of the health insurance concerns of large US employers conducted by the Business Group on Health.

Sixty-two percent of respondents believe both market-based and government reforms are needed to make the drug market competitive enough to...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet